|
19th Annual meeting PROGRAM |
2006
AMLI Annual Meeting
JW Marriott Hotel
Washington, DC
August 23-26, 2006
MEETING PROGRAM
Wednesday,
August 23, 2006
7:30 Breakfast
8:30-8:40
Opening Remarks
Barbara Detrick, Ph.D.
AMLI President
Plenary Session 1
8:45- 12:00
Immune Modulators in Disease: Key Targets
for Intervention and
Laboratory Monitoring
Chairs: Wayne Hogrefe, Ph.D. and
Barbara Detrick, Ph.D.
8:45
Cytokines: Biomarkers of Disease
Lyle
L. Moldawer, Ph.D.
9:20
Advances in Immune Based Therapies for Cancer
and Transplantation
Thomas
A. Waldmann, M.D.
10:00 Coffee Break
10:30
CD20 Targeted Antibodies: B-Cell Therapy in
Autoimmune Diseases
Robert A. Eisenberg, M.D.
11:15
Development of Biotherapeutics: Future Directions
and Laboratory
Implications
Lakshmi Amaravadi, Ph.D.
12:00-1:30 Luncheon Seminar
Host: Euroimmun US
“Determination of Autoantibodies against ANCA using
a Multiplex approach”
and
“Autoantibodies against cyclic citrullinated peptide
(CCP), a highly specific marker for rheumatoid
arthritis"
Speaker: Wolfgang Sclumberger, Ph.D.
Plenary Session 2
2:00-4:30
Case
Reports: Challenges in Clinical
Immunology
Chair: Thomas Alexander, Ph.D.
5:00-6:00
Abstract Award
Presentations
Chair: Ronald Harbeck,
Ph.D.
6:00-8:00
Poster Session,
Meet the Exhibitors
Wine and Cheese Reception
______________________________________________________
Thursday, August 24, 2006
7:30 Breakfast and
Committee Meetings
Plenary Session 3
8:30-12:00
New Insights:
Primary Immunodeficiencies
Chair: Karen Cost, Ph.D.
8:30
Immunodeficiency Disorders: General Considerations
and Laboratory
Evaluation
Thomas A. Fleisher, M.D.
9:15
DiGeorge Syndrome and Chromosome 22q11.2
Deletion Syndrome
Kathleen E. Sullivan, M.D., Ph.D.
10:00 Break
10:30 Interferon-g and IL-12 Pathway Defects in Primary
Immunodeficiency
Disorders
Gulbu Uzel, M.D.
11:15
Autoimmune Lymphoproliferative Syndrome (ALPS)
David Teachey, M.D.
12:00-1:30 Luncheon Seminar
Host: The Binding Site Inc.
“Recent Trends in the Diagnosis and Monitoring of
Multiple Myeloma and Other Monoclonal
Gammopathies”
Speaker: K. H. van Hoeven, M.D.
2:00- 3:00
Erwin Neter Memorial Lecture
Rebecca H. Buckley, M.D.
3:00-4:00 Business Meeting
4:30-6:00 Cocktail Hour,
Meet the Exhibitors
6:00-10:00 AMLI Annual Dinner
Dine
at the Sequoia Restaurant on Georgetown's beautiful waterfront. As the sun
dips below the spires of Georgetown University, the Sequoia and its
stunning views of the Potomac come to sparkling life. Featuring an
extensive contemporary American menu and a large variety of specialty
drinks, Sequoia plays host to Washington’s most notable citizens.
Follow dinner with a
self-exploration of Georgetown or take a moonlight trolley tour of
national monuments.
______________________________________________________
Friday, August 25, 2006
7:30 Breakfast and Committee Meetings
Plenary Session 4
8:30-12:00
Novel and Emerging Technologies: New
Frontiers in Laboratory Medicine
Chair: Maurice R. O’Gorman, Ph.D.
8:30
Novel Multiplex Technologies for Studying Autoimmunity
Steven
Chan, Ph.D.
9:15
Real Time Pharmacodynamics in Leukemia Clinical Trials
Using Flow
Cytometry
David
Hedley, M.D., Ph.D.
10:00 Break
10:30 Automated Approaches to Drug Delivery and Tissue
Engineering
Daniel G. Anderson, Ph.D.
11:15 Imaging Flow Cytometry: Visualizing Flow-Based
Immunological Assays
Albert D. Donnenberg, Ph.D.
12:00-1:30 Luncheon
Seminar Host: Beckman
Coulter, Inc
“ZAP-70 Protein Expression in Chronic Lymphocytic
Leukemia”
Speaker: T. Vincent Shankey, Ph.D.
Free Afternoon
____________________________________________________________
Saturday, August 26, 2006
Plenary Session 5
8:30- 12:00
Cutting Edge: Hot Topics in
Immunology
Chairs: John Schmitz,
Ph.D. and Ronald Harbeck, Ph.D.
8:30
Toll-Like Receptors: Overview and Role in Human Disease
Donald N. Cook, Ph.D.
9:15
Role of T Regulatory
Cells in Autoimmune Disease and
Potential Therapeutic Applications
Roland Tisch, Ph.D.
10:00 Break
10:30 New Molecular Approaches to Monitor Infectious
Diseases in
Transplantation
Lesia K. Dropulic, M.D.
11:15 Advances in Allergic Diseases: Assessment of
Anti-IgE Therapy
Robert G. Hamilton, Ph.D.
12-12:15
Closing Remarks
Barbara Detrick, Ph.D.
AMLI President
|